223 related articles for article (PubMed ID: 31559473)
1. Inflammatory mimickers of pancreatic adenocarcinoma.
Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
[TBL] [Abstract][Full Text] [Related]
2. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
3. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
[TBL] [Abstract][Full Text] [Related]
4. Chronic Pancreatitis or Pancreatic Tumor? A Problem-solving Approach.
Wolske KM; Ponnatapura J; Kolokythas O; Burke LMB; Tappouni R; Lalwani N
Radiographics; 2019; 39(7):1965-1982. PubMed ID: 31584860
[TBL] [Abstract][Full Text] [Related]
5. Imaging mimics of pancreatic ductal adenocarcinoma.
Gandhi NS; Feldman MK; Le O; Morris-Stiff G
Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
7. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma.
Iglesias-García J; Lindkvist B; Lariño-Noia J; Domínguez-Muñoz JE
Rev Esp Enferm Dig; 2012 Jun; 104(6):315-21. PubMed ID: 22738702
[TBL] [Abstract][Full Text] [Related]
8. Dual Pathology? Autoimmune Pancreatitis and Ductal Adenocarcinoma.
Sureka B; Bansal K
AJR Am J Roentgenol; 2015 Dec; 205(6):W643. PubMed ID: 26587956
[No Abstract] [Full Text] [Related]
9. Pancreatitis and PDAC: association and differentiation.
Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer and Its Mimics.
Miller FH; Lopes Vendrami C; Hammond NA; Mittal PK; Nikolaidis P; Jawahar A
Radiographics; 2023 Nov; 43(11):e230054. PubMed ID: 37824413
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
[TBL] [Abstract][Full Text] [Related]
12. Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography.
Zaheer A; Singh VK; Akshintala VS; Kawamoto S; Tsai SD; Gage KL; Fishman EK
J Comput Assist Tomogr; 2014; 38(1):146-52. PubMed ID: 24424563
[TBL] [Abstract][Full Text] [Related]
13. A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography.
Fukuda J; Tanaka S; Ishida N; Ioka T; Ikezawa K; Takakura R; Nakao M; Ohkawa K; Katayama K; Nagata S
J Med Ultrason (2001); 2018 Oct; 45(4):617-622. PubMed ID: 29470686
[TBL] [Abstract][Full Text] [Related]
14. Groove pancreatitis: a clinical and imaging overview.
Patel BN; Brooke Jeffrey R; Olcott EW; Zaheer A
Abdom Radiol (NY); 2020 May; 45(5):1439-1446. PubMed ID: 31559471
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
16. Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation.
Boninsegna E; Negrelli R; Zamboni GA; Tedesco G; Manfredi R; Pozzi Mucelli R
Eur J Radiol; 2017 Oct; 95():236-241. PubMed ID: 28987673
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
